Literature DB >> 23182551

From genes to metabolomics in renal cell carcinoma translational research.

Peter F A Mulders.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182551     DOI: 10.1016/j.eururo.2012.11.021

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Machine learning distilled metabolite biomarkers for early stage renal injury.

Authors:  Yan Guo; Hui Yu; Danqian Chen; Ying-Yong Zhao
Journal:  Metabolomics       Date:  2019-12-05       Impact factor: 4.290

2.  Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.

Authors:  Dan-Qian Chen; Gang Cao; Hua Chen; Christos P Argyopoulos; Hui Yu; Wei Su; Lin Chen; David C Samuels; Shougang Zhuang; George P Bayliss; Shilin Zhao; Xiao-Yong Yu; Nosratola D Vaziri; Ming Wang; Dan Liu; Jia-Rong Mao; Shi-Xing Ma; Jin Zhao; Yuan Zhang; You-Quan Shang; Huining Kang; Fei Ye; Xiao-Hong Cheng; Xiang-Ri Li; Li Zhang; Mei-Xia Meng; Yan Guo; Ying-Yong Zhao
Journal:  Nat Commun       Date:  2019-04-01       Impact factor: 14.919

3.  Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.

Authors:  Zhuolun Sun; Tengcheng Li; Chutian Xiao; Shaozhong Zou; Mingxiao Zhang; Qiwei Zhang; Zhenqing Wang; Hailun Zhan; Hua Wang
Journal:  World J Surg Oncol       Date:  2022-04-14       Impact factor: 2.754

4.  An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease.

Authors:  Fang Dou; Hua Miao; Jing-Wen Wang; Lin Chen; Ming Wang; Hua Chen; Ai-Dong Wen; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2018-02-08       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.